Obstetrics and Gynecology

1046 questions

Question 941Question →

A 44-year-old female presents to the physician 14 days after an uncomplicated total abdominal hysterectomy for symptomatic uterine leiomyomas. She reports a new onset of constant, clear, watery fluid leaking from her vagina that requires her to wear adult diapers. She maintains a normal sensation of bladder filling and is voiding normal volumes of urine voluntarily in the toilet. To evaluate the source of the leakage, she is given oral phenazopyridine. Two hours later, a cotton tampon is placed in the vaginal canal, and her bladder is filled with a solution of methylene blue via a transurethral catheter. The patient is asked to walk around for 20 minutes. Upon removal, the tampon shows prominent orange staining near its apex, with absolutely no blue discoloration. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Ureterovaginal fistula

Answer

Ureterovaginal fistula
The correct answer is ureterovaginal fistula. The patient's continuous vaginal leakage after a hysterectomy strongly suggests a urogenital fistula. To differentiate the anatomical source of the fistula, a double-dye test can be used. Oral phenazopyridine is excreted by the kidneys, turning all freshly produced urine orange. Methylene blue is instilled directly into the bladder via a catheter. If a patient has a vesicovaginal fistula, the blue dye from the bladder leaks directly into the vagina. If the patient has a ureterovaginal fistula, the intact bladder retains the blue dye, but the injured ureter leaks the orange urine directly into the vaginal vault. The presence of orange staining with the complete absence of blue staining definitively identifies a ureterovaginal fistula.

Step-by-Step Solution

1
Analyze the patient's postoperative clinical presentation.
The patient has continuous watery vaginal discharge 14 days after a hysterectomy but still voids normally.
Continuous leakage suggests a urogenital fistula. Normal voiding suggests that at least one ureter and the bladder are functioning and intact.
2
Interpret the underlying physiology of the double-dye test.
Oral phenazopyridine turns all renal urine orange. Methylene blue is artificially placed only inside the bladder.
This setup isolates the upper urinary tract (ureters, producing orange fluid) from the lower urinary tract (bladder, containing blue fluid).
3
Correlate the physical dye results with anatomical pathology.
The tampon is stained orange but completely lacks blue staining.
Because the blue dye did not leak, the bladder must be intact. Because the orange urine bypassed the bladder and entered the vagina, there must be a connection between the ureter and the vagina (ureterovaginal fistula).

Key Concept

Differentiating post-hysterectomy urinary fistulas using the double-dye (tampon) test.
Question 942Question →

A 2929-year-old woman, gravida 22, para 11, at 2222 weeks gestation presents to the clinic with severe vulvovaginal itching and a thick, white vaginal discharge for the past 55 days. She reports no abdominal pain, fever, or urinary symptoms. Her pregnancy has been uncomplicated. One month ago, she had a similar episode of vaginal itching that she self-treated with an over-the-counter 33-day course of intravaginal miconazole. Her symptoms temporarily improved but have now returned and are more severe. Vital signs are within normal limits. Pelvic examination reveals significant vulvar erythema, excoriations, and a thick, adherent, "cottage cheese-like" vaginal discharge. The cervix is closed, and there is no cervical motion tenderness. Vaginal pH is 4.24.2. Wet mount examination with potassium hydroxide (KOH) preparation reveals branching pseudohyphae and budding yeast. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intravaginal clotrimazole for 77 days

Answer

The most appropriate next step in management is a 77-day course of intravaginal clotrimazole.
The patient's presentation of severe vulvovaginal pruritus, thick "cottage cheese-like" discharge, normal vaginal pH (typically <4.5< 4.5), and pseudohyphae on potassium hydroxide (KOH) preparation confirms the diagnosis of vulvovaginal candidiasis (VVC). Management of VVC depends heavily on the patient's pregnancy status. In non-pregnant individuals, an uncomplicated episode is typically treated with a short 11- to 33-day course of topical azoles or a single dose of oral fluconazole. If symptoms are severe or refractory to topical therapy, the standard next step in a non-pregnant patient is systemic therapy with a multi-dose oral fluconazole regimen.

However, because this patient is pregnant, the treatment algorithm is tightly restricted. Systemic absorption of oral fluconazole has been strongly associated with an increased risk of spontaneous abortion and specific congenital malformations (e.g., tetralogy of Fallot, cleft palate, and skeletal abnormalities). Consequently, all oral azoles are strictly contraindicated throughout all trimesters of pregnancy. The Centers for Disease Control and Prevention (CDC) guidelines mandate that VVC in pregnant women be treated exclusively with topical azole therapies (e.g., clotrimazole, miconazole). Furthermore, because pregnant women possess higher levels of circulating estrogen (which increases vaginal glycogen content and promotes intense Candida overgrowth), achieving symptomatic relief often requires a longer duration of therapy. The standard recommendation is a continuous 77-day course of an intravaginal azole, which is highly effective and poses no known risks to the developing fetus.

Step-by-Step Solution

1
Identify the patient's diagnosis based on the clinical presentation and laboratory findings.
The patient has vulvovaginal candidiasis (VVC), evidenced by severe pruritus, thick white discharge, normal vaginal pH (4.24.2), and pseudohyphae on KOH prep.
Synthesizing the physical exam and wet mount findings is required to accurately distinguish VVC from bacterial vaginosis and trichomoniasis.
2
Evaluate the patient's physiological context and recent treatment history.
The patient is pregnant (2222 weeks gestation) and has recently failed a short 33-day course of topical antifungal therapy.
Pregnancy status and prior treatment failure are critical factors that drastically alter the standard therapeutic algorithm for VVC.
3
Determine the appropriate guideline-concordant pharmacotherapy that safely addresses a refractory or recurrent infection during pregnancy.
A 77-day course of a topical azole (e.g., intravaginal clotrimazole) is indicated. Systemic oral antifungals and alternative therapies like boric acid are contraindicated.
While non-pregnant patients with recurrent or refractory VVC would safely step up to oral fluconazole therapy, pregnant patients must strictly utilize extended topical azole regimens to avoid severe teratogenic risks.

Key Concept

Management of vulvovaginal candidiasis in pregnancy requires the exclusive use of topical azole therapies for an extended 77-day duration, as systemic oral fluconazole and intravaginal boric acid are strictly contraindicated due to significant teratogenic risks.
Question 943Question →

An evaluation is requested for a female patient experiencing persistent, unpredictable vaginal spotting over the last 8 weeks. The patient is 38 years of age and has never been pregnant. Her gynecologic history is notable for oligomenorrhea since adolescence, with menses occurring only two to three times per year. She also reports long-standing struggles with excess facial hair and obesity; her current body mass index is 37 kg/m². Pelvic examination reveals no active bleeding from the cervical os and normal-appearing vaginal mucosa. Transvaginal ultrasonography is performed and demonstrates an endometrial stripe measuring 17 mm in thickness, alongside bilaterally enlarged ovaries containing numerous small peripheral follicles. Which of the following is the most appropriate next step in the management of this patient's condition?

Show answer & explanation

Answer: Office endometrial biopsy

Answer

Office endometrial biopsy
The most appropriate next step is an office endometrial biopsy. This patient presents with abnormal uterine bleeding in the setting of chronic anovulation (suggested by oligomenorrhea, hyperandrogenism, and polycystic-appearing ovaries) and obesity. In anovulatory cycles, the endometrium is exposed to continuous estrogen without the stabilizing effect of progesterone, leading to endometrial proliferation. Peripheral aromatization of androgens to estrone in adipose tissue further compounds this risk. Although endometrial biopsy is universally recommended for abnormal bleeding in women aged 45 years and older, it is also explicitly indicated in women under 45 years who have significant risk factors for unopposed estrogen exposure. Her significantly thickened endometrial stripe (17 mm) reinforces the urgent need to rule out malignant or premalignant changes before initiating any medical therapy.

Step-by-Step Solution

1
Identify the patient's risk factors for endometrial pathology based on the clinical presentation.
The patient has chronic anovulation (evidenced by oligomenorrhea and polycystic-appearing ovaries) and severe obesity (BMI 37 kg/m²).
These factors result in prolonged, unopposed estrogen exposure, significantly increasing the risk of endometrial hyperplasia and carcinoma.
2
Evaluate the indication for endometrial sampling based on patient age and risk profile.
Although the patient is under 45 years old, her significant risk factors and thickened endometrium (17 mm) meet the criteria for immediate endometrial sampling.
Guidelines mandate biopsy in women under 45 with abnormal uterine bleeding if they have a history of unopposed estrogen exposure.
3
Select the most appropriate initial diagnostic modality.
An office endometrial biopsy is chosen over immediate treatment or more invasive procedures.
A definitive tissue diagnosis must precede any hormonal treatment to accurately rule out endometrial cancer.

Key Concept

In women under 45 years of age presenting with abnormal uterine bleeding, an office endometrial biopsy is required if there are significant risk factors for unopposed estrogen exposure (such as obesity and chronic anovulation) to rule out endometrial hyperplasia and carcinoma.
Estimated Time:1m 15s
Question 944Question →

A 32-year-old gravida 2, para 1 at 39 weeks gestation is admitted to the labor and delivery unit in active labor. Her prenatal course has been uncomplicated. On admission, her cervical examination shows 6 cm dilation, 100% effacement, and the fetal presenting part is at -2 station. Thirty minutes later, the patient experiences spontaneous rupture of membranes with a large gush of clear fluid. The continuous fetal heart rate monitor immediately shows a prolonged deceleration to 70/min that does not resolve. A subsequent sterile vaginal examination reveals a pulsating, smooth, rope-like structure in the vaginal canal ahead of the fetal head. Which of the following is the most appropriate initial next step in management?

Show answer & explanation

Answer: Manual elevation of the fetal presenting part

Answer

Manual elevation of the fetal presenting part
The patient's presentation of sudden, prolonged fetal bradycardia immediately after rupture of membranes, combined with a palpable pulsating mass in the vagina, is diagnostic of an umbilical cord prolapse. Because the fetal presenting part compresses the umbilical cord against the maternal pelvis, blood flow to the fetus is acutely cut off. The most critical initial step in management is to have an examiner insert a hand into the vagina and manually elevate the fetal presenting part off the prolapsed cord. This hand must remain in place to maintain decompression while the patient is urgently transferred to the operating room for an emergent cesarean delivery.

Step-by-Step Solution

1
Analyze the clinical presentation
The patient has ruptured membranes, prolonged fetal bradycardia, and a palpable pulsating structure in the vagina.
This constellation of findings is the classic presentation of an overt umbilical cord prolapse.
2
Determine the immediate pathophysiologic threat
The fetal presenting part is compressing the umbilical cord against the maternal pelvis, obstructing fetal blood flow.
Cord compression rapidly leads to fetal hypoxia, acidosis, and death if not corrected immediately.
3
Select the most appropriate initial intervention
The initial maneuver is to manually elevate the fetal presenting part off the umbilical cord.
This mechanical relief is the most rapid and effective way to restore perfusion to the fetus while arranging for definitive management (emergent cesarean delivery).

Key Concept

Overt umbilical cord prolapse is an obstetric emergency requiring immediate mechanical decompression of the cord by manually elevating the fetal presenting part, followed by emergent cesarean delivery.
Question 945Question →

Match each clinical presentation of a gynecologic neoplasm with its most likely diagnosis.

Click a left item, then click its matching right item

Items

A 19-year-old woman with a large unilateral adnexal mass, elevated lactate dehydrogenase (LDH), and normal alpha-fetoprotein (AFP)
A 58-year-old woman with a unilateral adnexal mass, postmenopausal bleeding, and endometrial complex atypical hyperplasia
A 24-year-old woman with a rapidly growing adnexal mass, markedly elevated alpha-fetoprotein (AFP), and Schiller-Duval bodies on histology
A 64-year-old woman with diffuse abdominal bloating, early satiety, ascites, bilateral complex adnexal masses, and elevated CA-125

Matches

Show answer & explanation

Answer

The correct pairings match the specific tumor markers, clinical demographics, and histologic findings to their respective ovarian neoplasms.
Each clinical scenario features hallmark characteristics of specific ovarian tumors. Dysgerminoma correlates with LDH; Granulosa cell tumor with estrogenic effects (endometrial hyperplasia); Endodermal sinus tumor with AFP and Schiller-Duval bodies; Epithelial ovarian carcinoma with CA-125 and advanced presentation with ascites.

Step-by-Step Solution

1
Analyze the presentation of the 19-year-old with elevated LDH and normal AFP.
This marker profile points to a dysgerminoma.
Dysgerminomas are the most common malignant germ cell tumors in young women and classically secrete LDH, while AFP remains normal.
2
Analyze the presentation of the 58-year-old with postmenopausal bleeding and endometrial hyperplasia.
This presentation aligns with a granulosa cell tumor.
Granulosa cell tumors are estrogen-secreting tumors that cause peripheral endometrial proliferation, necessitating an endometrial biopsy to rule out concurrent endometrial malignancy.
3
Analyze the presentation of the 24-year-old with elevated AFP and Schiller-Duval bodies.
This is diagnostic of an endodermal sinus (yolk sac) tumor.
Schiller-Duval bodies (resembling glomeruli) and elevated AFP are pathognomonic for yolk sac tumors.
4
Analyze the presentation of the 64-year-old with advanced age, ascites, and elevated CA-125.
This clinical picture represents epithelial ovarian carcinoma.
Epithelial ovarian cancers typically present in postmenopausal women with non-specific gastrointestinal symptoms, ascites, and elevated CA-125.

Key Concept

Differentiation of ovarian neoplasms by their characteristic tumor markers, patient demographics, and histologic features.
Question 946Question →

A 26-year-old woman is evaluated in the office alongside her husband due to primary infertility. The couple has engaged in regular, unprotected vaginal intercourse for the past 16 months without achieving pregnancy. The patient reports that her menstrual periods are highly unpredictable, typically occurring at 60- to 90-day intervals. Over the last three years, she has noticed the gradual onset of coarse, dark hair growing on her upper lip and chin, which she manages by daily plucking. She has no chronic medical conditions and takes no medications other than a prenatal vitamin. Vital signs are within normal limits. Her body mass index is 29 kg/m229 \text{ kg/m}^2. Physical examination demonstrates a female escutcheon and normal external genitalia without clitoromegaly. A bimanual pelvic examination is unremarkable. The partner's semen analysis parameters are within normal reference ranges. A transvaginal ultrasound reveals bilaterally enlarged ovaries, each containing 15 to 20 small, peripherally oriented follicles. Serum concentrations of prolactin and thyroid-stimulating hormone are normal. The clinician suspects polycystic ovary syndrome (PCOS). To definitively establish this diagnosis, which of the following is the most appropriate next step in the laboratory evaluation?

Show answer & explanation

Answer: Basal serum 17-hydroxyprogesterone concentration

Answer

Basal serum 17-hydroxyprogesterone concentration
The patient presents with clinical hyperandrogenism, oligo-ovulation, and polycystic ovaries on transvaginal ultrasound. While these findings satisfy the Rotterdam criteria for polycystic ovary syndrome (PCOS), PCOS remains a diagnosis of exclusion. Non-classic congenital adrenal hyperplasia (NCAH), primarily due to partial 21-hydroxylase deficiency, can present with identical clinical, metabolic, and sonographic findings. Therefore, authoritative guidelines mandate screening all women with suspected PCOS for NCAH by measuring an early morning (basal) 17-hydroxyprogesterone concentration. If the level is elevated, an ACTH stimulation test is performed to confirm NCAH.

Step-by-Step Solution

1
Identify the primary clinical presentation.
The patient has oligo-ovulation (irregular menses), clinical hyperandrogenism (hirsutism), and polycystic ovaries on ultrasound.
These three findings satisfy the Rotterdam criteria, making polycystic ovary syndrome (PCOS) the most likely diagnosis.
2
Recognize the diagnostic requirement for PCOS.
PCOS is strictly a diagnosis of exclusion.
Other endocrinopathies that cause hyperandrogenism and anovulation must be biochemically ruled out before confirming PCOS.
3
Determine the necessary screening test based on the patient's presentation.
The patient requires screening for non-classic congenital adrenal hyperplasia (NCAH) using a basal 17-hydroxyprogesterone level.
NCAH caused by 21-hydroxylase deficiency can perfectly mimic the clinical and sonographic features of PCOS without causing severe virilization.

Key Concept

Polycystic ovary syndrome (PCOS) is a diagnosis of exclusion; all patients with suspected PCOS must be screened for non-classic congenital adrenal hyperplasia (NCAH) using a basal early morning 17-hydroxyprogesterone concentration.
Question 947Question →

An 82-year-old woman is brought to the clinic by her daughter due to a 3-month history of urinary incontinence. The patient experiences a sudden, overwhelming urge to urinate and frequently leaks urine before reaching the bathroom. She has a history of hypertension, Alzheimer dementia, and narrow-angle glaucoma. Her current medications include lisinopril, donepezil, and timolol ophthalmic drops. Vital signs are within normal limits. Abdominal examination reveals no suprapubic tenderness. Pelvic examination shows normal postmenopausal vaginal mucosa and no evidence of pelvic organ prolapse. A post-void residual volume is 40 mL. Urinalysis is negative for leukocyte esterase and nitrites. The patient has attempted timed voiding and pelvic floor muscle exercises for the past 6 weeks without significant improvement. Which of the following is the most appropriate pharmacotherapy for this patient's urinary symptoms?

Show answer & explanation

Answer: Mirabegron

Answer

Mirabegron
Mirabegron is a beta-3 adrenergic agonist that causes detrusor muscle relaxation, increasing bladder capacity and effectively treating urgency urinary incontinence. It is the most appropriate choice for this patient because she has Alzheimer dementia and narrow-angle glaucoma, both of which are major contraindications to antimuscarinic medications (the other first-line therapy for overactive bladder). Furthermore, antimuscarinics would directly antagonize the mechanism of donepezil, an acetylcholinesterase inhibitor used to manage her dementia.

Step-by-Step Solution

1
Identify the type of urinary incontinence based on the clinical presentation.
The patient has sudden, overwhelming urges to urinate with subsequent leakage, indicating urgency urinary incontinence (overactive bladder).
Determining the specific mechanism of incontinence (stress, urgency, or overflow) is required to guide targeted therapy.
2
Evaluate the patient's medical history for medication contraindications.
The patient has Alzheimer dementia (treated with donepezil, an acetylcholinesterase inhibitor) and narrow-angle glaucoma.
First-line pharmacotherapies for urgency incontinence often have systemic side effects that can dangerously exacerbate pre-existing conditions.
3
Select the appropriate medication class that avoids these contraindications.
A beta-3 adrenergic agonist (mirabegron) is selected over antimuscarinic medications.
Antimuscarinics would directly antagonize her dementia medication, worsen cognitive impairment, and are strictly contraindicated in narrow-angle glaucoma. Mirabegron relaxes the detrusor muscle without these anticholinergic adverse effects.

Key Concept

Management of urgency urinary incontinence in patients with contraindications to antimuscarinic therapy
Question 948Question →

Match each acute obstetric emergency vignette to the most appropriate immediate next step in management.

Click a left item, then click its matching right item

Items

A 34-year-old multipara develops sudden-onset hypoxia, cyanosis, and profound hypotension shortly after delivery of the placenta, rapidly followed by oozing from her intravenous catheter site.
A 26-year-old primipara experiences a massive gush of blood following excessive umbilical cord traction. Pelvic examination reveals a purple-red mass at the introitus; the uterine fundus is impalpable transabdominally.
A 31-year-old multipara undergoes amniotomy at 38 weeks gestation. She immediately develops painless vaginal bleeding, and the fetal heart tracing demonstrates abrupt, prolonged bradycardia.
A 38-year-old gravida 4 is pushing in the second stage of labor. The fetal head delivers but immediately retracts tightly against the maternal perineum. Gentle downward traction is ineffective.

Matches

Show answer & explanation

Answer

The correct pairings match each classic obstetric emergency presentation with its definitive acute management: Amniotic fluid embolism requires aggressive supportive care with CPR and blood products; Uterine inversion requires immediate manual replacement without uterotonics; Ruptured vasa previa necessitates emergent cesarean delivery; and Shoulder dystocia is managed initially with the McRoberts maneuver.
Each correct pairing links a life-threatening obstetric complication directly to its recognized, evidence-based initial intervention. Recognizing the pathognomonic clinical signs (e.g., turtle sign, absent fundus, post-amniotomy bleeding) is the key to selecting the correct pathway.

Step-by-Step Solution

1
Analyze the clinical signs in each vignette to establish the underlying obstetric diagnosis.
Identified the conditions as amniotic fluid embolism, uterine inversion, ruptured vasa previa, and shoulder dystocia.
Accurate diagnosis is required because each of these emergencies dictates a completely distinct and immediate physiological intervention.
2
Evaluate the definitive next step for the identified conditions.
Matched each condition to its life-saving management protocol (e.g., stopping uterotonics for inversion, rapid delivery for vasa previa).
In obstetric emergencies, initiating the correct first-line therapy without delay significantly reduces maternal and fetal morbidity.

Key Concept

Immediate triage and definitive management of acute intrapartum and postpartum obstetric emergencies.
Question 949Question →

A 31-year-old woman presents to the clinic with a 6-month history of absent menses and new-onset, spontaneous bilateral milky nipple discharge. She has no headaches or visual changes and takes no medications. Physical examination confirms bilateral galactorrhea but is otherwise unremarkable. Visual fields are full to confrontation.

Arrange the following steps in the most appropriate chronological sequence for the evaluation and management of this patient, starting with the initial diagnostic test and progressing to the management of a refractory condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Perform a urine beta-human chorionic gonadotropin test, 2) Measure fasting serum prolactin and thyroid-stimulating hormone (TSH) levels, 3) Obtain magnetic resonance imaging (MRI) of the brain and pituitary sella, 4) Initiate medical therapy with a dopamine agonist, and 5) Refer the patient for transsphenoidal surgical resection.
The correct evaluation of secondary amenorrhea and galactorrhea follows a strict stepwise approach to minimize unnecessary testing and ensure patient safety. Pregnancy must always be excluded first (beta-hCG). Once excluded, biochemical testing for primary hypothyroidism and hyperprolactinemia (TSH and prolactin) is indicated. If hyperprolactinemia is confirmed and not due to hypothyroidism or medications, an MRI of the brain is obtained to identify a pituitary adenoma. The first-line treatment for a prolactinoma is a dopamine agonist (cabergoline). Transsphenoidal surgery is reserved strictly for refractory cases or when patients develop severe, progressive visual impairment despite maximal medical therapy.

Step-by-Step Solution

1
Rule out pregnancy
Perform a urine beta-hCG test
Pregnancy is the most common cause of secondary amenorrhea and can cause galactorrhea. It must be excluded before any further diagnostic testing or imaging is performed.
2
Evaluate for common endocrine etiologies
Measure TSH and prolactin levels
Primary hypothyroidism can lead to increased thyrotropin-releasing hormone (TRH), which stimulates prolactin release. Evaluating TSH and prolactin differentiates between primary hyperprolactinemia and secondary hyperprolactinemia due to hypothyroidism.
3
Localize the source of confirmed hyperprolactinemia
Obtain an MRI of the pituitary sella
Once non-pituitary causes of hyperprolactinemia are ruled out, imaging is necessary to identify potential pituitary adenomas (prolactinomas) or other sellar masses.
4
Provide first-line treatment for a prolactinoma
Initiate a dopamine agonist (e.g., cabergoline)
Unlike most other pituitary tumors, the first-line treatment for both micro- and macroprolactinomas is medical therapy with dopamine agonists, which decrease prolactin secretion and reduce tumor size.
5
Manage refractory disease
Refer for transsphenoidal surgery
Surgery is indicated only when medical therapy fails, is not tolerated, or if the patient experiences rapidly progressive visual field defects that do not respond to dopamine agonists.

Key Concept

The diagnostic and management algorithmic sequence for secondary amenorrhea with galactorrhea.
Question 950Question →

Match each diagnostic finding from the clinical evaluation of female urinary incontinence to its most appropriate corresponding diagnosis or pathophysiology.

Click a left item, then click its matching right item

Items

Involuntary leakage of urine synchronous with coughing, accompanied by a Q-tip test angle of 45 degrees from the horizontal.
Sudden, compelling desire to void accompanied by spontaneous, uninhibited bladder contractions at low volumes on a cystometrogram.
Continuous vaginal pooling of fluid; fluid does not turn blue after intravesical instillation of methylene blue, but turns blue after intravenous indigo carmine administration.
Constant urinary dribbling, poor urinary stream, and a post-void residual (PVR) volume of 450 mL on bladder ultrasound.

Matches

Show answer & explanation

Answer

The correct matches align specific urodynamic and physical test findings with their mechanisms: stress incontinence correlates with urethral hypermobility (Q-tip > 30 degrees), urgency incontinence correlates with detrusor overactivity, ureterovaginal fistula correlates with a positive IV dye test but negative bladder dye test, and overflow incontinence correlates with an elevated post-void residual volume.
Each specific diagnostic finding uniquely points to a distinct pathophysiological mechanism of incontinence. Q-tip testing evaluates physical urethral mobility (stress), cystometry evaluates detrusor muscle stability (urgency), double-dye testing differentiates urinary tract fistula locations, and post-void residual volume evaluates bladder emptying capacity (overflow).

Step-by-Step Solution

1
Evaluate the finding of urine leakage synchronous with coughing and a Q-tip test angle of 45 degrees.
This indicates urethral hypermobility.
A Q-tip angle greater than 30 degrees from the horizontal upon straining demonstrates a loss of adequate pelvic floor support at the urethrovesical junction, leading directly to stress urinary incontinence.
2
Evaluate the finding of a sudden urge to void and uninhibited contractions on cystometry.
This indicates detrusor overactivity.
Spontaneous bladder muscle (detrusor) contractions at low volumes during the filling phase are the defining urodynamic feature of urgency urinary incontinence.
3
Evaluate the finding of clear vaginal pooling with a negative intravesical methylene blue test but a positive intravenous indigo carmine test.
This indicates a ureterovaginal fistula.
Intravesical methylene blue stays in the bladder, meaning there is no hole between the bladder and vagina. Intravenous indigo carmine is excreted by the kidneys through the ureters; its appearance in the vagina confirms a communication between a ureter and the vagina.
4
Evaluate the finding of constant dribbling, poor stream, and a post-void residual (PVR) of 450 mL.
This indicates overflow incontinence.
A high PVR (generally >150-200 mL) demonstrates a failure to empty the bladder adequately, which results in overdistension and continuous small-volume leakage (overflow) due to either detrusor underactivity or mechanical outlet obstruction.

Key Concept

The pathophysiology and diagnostic evaluation of distinct female urinary incontinence subtypes and pelvic fistulas.
Question 951Question →

A 2828-year-old woman is evaluated for a 1212-month history of secondary amenorrhea and inability to conceive. She had irregular menses since menarche and was diagnosed with polycystic ovary syndrome (PCOS) at age 2121 due to oligomenorrhea and hirsutism. Over the past year, her menses ceased entirely. She also reports progressive fatigue, cold intolerance, and occasional morning headaches. Her BMI is 32 kg/m232 \text{ kg/m}^2. Physical examination reveals coarse terminal hair on her chin and upper lip, unchanged from previous visits. Neurologic examination shows a visual field defect in the bilateral temporal fields.

Laboratory evaluation reveals:
Follicle-stimulating hormone: 2 mIU/mL2 \text{ mIU/mL} (normal: 4−30 mIU/mL4-30 \text{ mIU/mL})
Luteinizing hormone: 1 mIU/mL1 \text{ mIU/mL} (normal: 2−20 mIU/mL2-20 \text{ mIU/mL})
Prolactin: 58 ng/mL58 \text{ ng/mL} (normal: <20 ng/mL<20 \text{ ng/mL})
Thyroid-stimulating hormone: 0.2 mIU/L0.2 \text{ mIU/L} (normal: 0.4−4.0 mIU/L0.4-4.0 \text{ mIU/L})
Free thyroxine (T4): 0.4 ng/dL0.4 \text{ ng/dL} (normal: 0.9−1.7 ng/dL0.9-1.7 \text{ ng/dL})

Which of the following is the most likely underlying cause of this patient's current amenorrhea?

Show answer & explanation

Answer: Compression of the pituitary stalk and functional anterior pituitary tissue

Answer

Compression of the pituitary stalk and functional anterior pituitary tissue
The correct answer is compression of the pituitary stalk and functional anterior pituitary tissue. This patient presents with bitemporal hemianopsia, hypogonadotropic hypogonadism (low FSH/LH, complete amenorrhea), and central hypothyroidism (low TSH, low free T4). Together, these findings strongly indicate a large sellar mass (macroadenoma) extending suprasellarly to compress both the optic chiasm and the normal pituitary gland. Her mild hyperprolactinemia (58 ng/mL58 \text{ ng/mL}) is characteristic of the 'stalk effect.' Dopamine from the hypothalamus tonically inhibits prolactin release from lactotrophs. A large, nonfunctioning mass compresses the pituitary stalk, disrupting dopaminergic transport and resulting in mild prolactin elevation (typically <100−200 ng/mL< 100-200 \text{ ng/mL}). In contrast, true macroprolactinomas generally secrete prolactin at much higher levels, often >1000 ng/mL> 1000 \text{ ng/mL}.

Step-by-Step Solution

1
Analyze the patient's neurological findings.
The patient has bitemporal hemianopsia and morning headaches, indicating a mass lesion near the optic chiasm, most likely a pituitary macroadenoma.
Identifying the structural lesion narrows the differential diagnosis to sellar or suprasellar masses.
2
Interpret the thyroid function tests.
TSH is low (0.2 mIU/L0.2 \text{ mIU/L}) and Free T4 is low (0.4 ng/dL0.4 \text{ ng/dL}), confirming central (secondary) hypothyroidism.
Differentiates pituitary/hypothalamic dysfunction from primary thyroid failure (which would have high TSH).
3
Interpret the gonadotropin and prolactin levels in the context of the sellar mass.
FSH and LH are low (hypogonadotropic hypogonadism). Prolactin is mildly elevated (58 ng/mL58 \text{ ng/mL}) but less than 200 ng/mL200 \text{ ng/mL}.
The combination of hypopituitarism and mild hyperprolactinemia in the setting of a large mass points to stalk compression (loss of dopamine inhibition) by a nonfunctioning adenoma, rather than a true prolactinoma.

Key Concept

Nonfunctioning pituitary macroadenomas can present with mass effect (bitemporal hemianopsia), panhypopituitarism (central hypothyroidism, hypogonadotropic hypogonadism), and mild hyperprolactinemia due to pituitary stalk compression (stalk effect).
Estimated Time:1m 30s
Question 952Question →

A woman in her first pregnancy is brought to the emergency department at 36 weeks and 4 days of gestation complaining of acute difficulty breathing. She reports a two-day history of a severe, unremitting headache and visual scotomas. She has no significant past medical history and takes no medications. Vital signs are temperature 37.0°C (98.6°F), blood pressure 182/114 mmHg, pulse 112/min, and respirations 28/min. Oxygen saturation is 86% on room air. Physical examination reveals generalized facial puffiness and marked pitting edema of both lower extremities extending to the knees. Auscultation of the lungs reveals diffuse bilateral crackles in the lower and middle lung fields. A continuous fetal monitor is placed. The uterine tocodynamometer shows contractions every 4 minutes. The fetal heart rate tracing reveals a baseline of 145/min, moderate variability, and recurrent, gradual decreases in heart rate with nadirs occurring after the peaks of the contractions. Which of the following is the most appropriate initial step in the management of this patient?

Show answer & explanation

Answer: Administration of supplemental oxygen and intravenous furosemide

Answer

Administration of supplemental oxygen and intravenous furosemide is required to stabilize the mother's acute pulmonary edema prior to any operative intervention.
The correct intervention is the administration of supplemental oxygen and intravenous furosemide. This patient is experiencing acute pulmonary edema secondary to preeclampsia with severe features, a life-threatening obstetric complication caused by increased systemic vascular resistance, endothelial damage, and decreased plasma oncotic pressure. Although the fetal heart rate tracing shows late decelerations (indicating uteroplacental insufficiency), maternal stabilization is the absolute first priority. Immediate management includes oxygen supplementation, loop diuretics (furosemide) to reduce preload and pulmonary fluid, and blood pressure control. Only after the mother is hemodynamically stable should the team proceed with delivery, which is the definitive treatment for preeclampsia.

Step-by-Step Solution

1
Identify the primary maternal clinical syndrome based on vital signs and physical exam.
Severe hypertension, unremitting headache, scotomas, generalized edema, and bilateral pulmonary crackles indicate preeclampsia with severe features complicated by acute pulmonary edema.
Recognizing the life-threatening complication of preeclampsia dictates the urgency and type of medical intervention needed.
2
Interpret the fetal heart rate (FHR) tracing findings.
Gradual decreases in heart rate with nadirs occurring after the peak of contractions indicate late decelerations, a sign of uteroplacental insufficiency.
Fetal status must be evaluated alongside maternal status, as maternal hypoxemia often causes secondary fetal distress.
3
Determine the prioritized next step in management.
Maternal hemodynamic and respiratory stabilization must precede delivery.
Anesthetizing and operating on an unstable, severely hypoxemic patient carries an unacceptably high risk of maternal mortality. Oxygen and loop diuretics will improve maternal oxygenation and consequently improve the fetal status.

Key Concept

In patients presenting with acute obstetric emergencies such as preeclamptic pulmonary edema combined with fetal distress, maternal stabilization (using oxygen, antihypertensives, and diuretics) must always precede emergency delivery.
Question 953Question →

A 47-year-old G2P2 patient presents to the clinic for her annual preventive health visit. She feels well and reports no pelvic pain, vaginal discharge, or abnormal bleeding. Her menstrual cycles remain regular, occurring every 29 days with 5 days of normal flow. Her last menstrual period ended two weeks ago. Medical history is unremarkable, and she takes no medications. Vital signs are normal. Speculum examination reveals a normal, parous cervix without visible lesions. Bimanual examination demonstrates a mobile, non-enlarged uterus and no adnexal masses. A sample obtained for cervical cancer screening shows "negative for intraepithelial lesion or malignancy" with the presence of "benign endometrial cells." Concurrent testing for high-risk human papillomavirus (HPV) is negative. Which of the following is the most appropriate next step in the care of this patient?

Show answer & explanation

Answer: Endometrial biopsy

Answer

Endometrial biopsy
The most appropriate next step in management is an endometrial biopsy. According to guidelines from the American Society for Colposcopy and Cervical Pathology (ASCCP) and the American College of Obstetricians and Gynecologists (ACOG), the presence of benign endometrial cells on cervical cytology in women aged 45 years and older requires direct endometrial evaluation. While it is normal for premenopausal women to shed endometrial cells during the first half of their menstrual cycle, this finding becomes increasingly associated with endometrial hyperplasia or carcinoma as women age. Therefore, the age cutoff of 45 was established to ensure that potential uterine malignancies are not missed, regardless of the patient's menopausal status, symptom profile, or the specific day of her menstrual cycle. The negative HPV test and lack of cervical dysplasia indicate that her risk for cervical cancer is low, but the endometrial cavity must still be sampled.

Step-by-Step Solution

1
Analyze the patient's demographic and clinical presentation.
The patient is a 47-year-old premenopausal woman with regular cycles and an asymptomatic presentation.
Age is a critical determinant in the management of incidental findings on cervical cytology.
2
Evaluate the cervical cytology and HPV testing results.
The Pap test is negative for dysplasia but shows benign endometrial cells. The HPV test is negative.
Cytology results dictate the next step in the cervical cancer screening algorithm.
3
Apply clinical guidelines for the specific cytology finding.
According to ASCCP and ACOG guidelines, the presence of endometrial cells on cytology in any woman aged 45 years or older necessitates an endometrial biopsy.
Shedding of endometrial cells in this age group carries a higher risk of underlying endometrial hyperplasia or cancer, even if the cells appear benign and the patient is asymptomatic.

Key Concept

Women aged 45 years and older who have benign endometrial cells reported on cervical cytology require an endometrial biopsy, regardless of their menopausal status or the presence of symptoms.
Estimated Time:1m 30s
Question 954Question →

A 66-year-old G4P4 woman comes to the office due to a 9-month history of a persistent vaginal bulge. She reports that the sensation of fullness worsens after prolonged standing or lifting groceries and improves when she lies down. Additionally, the patient has developed difficulty emptying her bladder over the past 3 months. She notes that she must apply manual upward pressure on the vaginal bulge with her fingers to successfully initiate and complete urination. She denies urinary leakage with coughing, sudden overwhelming urges to urinate, dysuria, or constipation. She has a history of type 2 diabetes mellitus and hypertension. Pelvic examination reveals a soft, reducible mass protruding from the anterior vaginal wall that descends to the introitus during the Valsalva maneuver. The posterior vaginal wall and vaginal apex demonstrate normal support without descent. Which of the following is the most likely anatomic etiology of this patient's current symptoms?

Show answer & explanation

Answer: Defect in the pubocervical fascia

Answer

Defect in the pubocervical fascia
The correct answer identifies a defect in the pubocervical fascia. This patient's physical examination demonstrates an anterior vaginal wall prolapse, commonly known as a cystocele. The anterior vaginal wall is structurally supported by the pubocervical fascia; when this fascia is damaged or attenuated (often due to multiparity, aging, or elevated intra-abdominal pressure), the bladder can herniate into the anterior vagina. Clinically, a large cystocele can drag the bladder base downward while the distal urethra remains fixed, creating a kink in the urethra. This mechanical urethral kinking leads to bladder outlet obstruction and incomplete emptying. Patients classicly report having to manually elevate the prolapsed bladder (digital splinting) to straighten the urethra and allow urine to flow.

Step-by-Step Solution

1
Analyze the patient's symptoms and physical examination findings.
The patient has an anterior vaginal wall mass (bulge) and urinary retention requiring digital splinting (manual elevation) to successfully void.
Identifying the affected vaginal compartment and correlated symptoms isolates the specific type of pelvic organ prolapse.
2
Correlate the physical finding with the supporting pelvic anatomy.
The anterior vaginal wall is normally supported by the pubocervical fascia. A defect here allows the bladder to herniate, forming a cystocele.
Understanding pelvic floor anatomy is essential to link the clinical presentation (anterior bulge) to the exact anatomic failure.
3
Explain the pathophysiologic mechanism of the voiding dysfunction.
A large cystocele displaces the bladder downward, which can create a sharp angle or 'kink' in the urethra, leading to bladder outlet obstruction and the need to manually reduce the prolapse to straighten the urethra and void.
This confirms why splinting relieves the patient's urinary retention, securing the diagnosis.

Key Concept

Anterior vaginal wall prolapse (cystocele) is caused by a defect in the pubocervical fascia. It typically presents with a vaginal bulge and, in advanced stages, can kink the urethra, causing urinary retention that necessitates digital splinting to void.
Question 955Question →

A multiparous patient (G3P2) at 40 weeks of gestation is in the active pushing phase of labor. Her pregnancy was complicated by gestational diabetes. Following the emergence of the fetal head, it promptly retracts against the perineal tissue (turtle sign). Standard downward traction is unsuccessful in delivering the anterior shoulder. The attending clinician immediately calls for assistance.

Arrange the following obstetric interventions in the most appropriate sequential order for managing this complication, starting from the recommended initial maneuver to the procedure of last resort.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing shoulder dystocia is the McRoberts maneuver, followed by suprapubic pressure, internal maneuvers such as delivery of the posterior arm, and finally cephalic replacement (Zavanelli maneuver) if all else fails.
Shoulder dystocia is an acute obstetric emergency requiring a protocol-driven, stepwise approach. Once help is called, the first intervention is the McRoberts maneuver (hyperflexion of the maternal hips), often paired with suprapubic pressure, which collectively resolve most cases by altering the pelvic diameter and dislodging the anterior shoulder. If these external maneuvers fail, internal maneuvers such as delivering the posterior arm or performing the Woods corkscrew are attempted to manually reduce the fetal shoulder diameter. When all standard external and internal maneuvers fail, last-resort salvage procedures like the Zavanelli maneuver (replacing the fetal head into the vagina to allow for cesarean delivery) are utilized.

Step-by-Step Solution

1
Recognize the clinical signs of shoulder dystocia
The turtle sign (retraction of the fetal head) and failure of standard downward traction indicate the diagnosis.
Prompt recognition is essential to rapidly initiate the emergency algorithm and minimize the risk of fetal hypoxic injury.
2
Initiate first-line external maneuvers
Perform the McRoberts maneuver and apply suprapubic pressure.
These techniques are non-invasive, quick to execute, and resolve the vast majority of shoulder dystocia cases.
3
Proceed to internal maneuvers if external techniques are unsuccessful
Attempt to deliver the posterior fetal arm or perform rotational maneuvers.
Internal maneuvers actively reduce the fetal bisacromial diameter and physically alter the position of the impacted shoulders.
4
Execute salvage procedures as a last resort
Perform cephalic replacement (Zavanelli maneuver) followed by an emergency cesarean delivery.
This intervention carries significant maternal and fetal morbidity and is strictly reserved for refractory cases.

Key Concept

The stepwise management of shoulder dystocia prioritizes non-invasive external maneuvers (McRoberts, suprapubic pressure) before progressing to internal maneuvers (delivery of posterior arm) and finally extreme salvage procedures (Zavanelli maneuver).
Estimated Time:1m 30s
Question 956Question →

A 26-year-old nulligravid woman comes to the office due to a 6-month history of absent menses. Prior to this, her menses occurred at regular 28-day intervals. She also reports frequent difficulty sleeping and episodic feelings of intense warmth and sweating over the past 3 months. She has no significant past medical history and takes no medications. Her temperature is 37.0°C (98.6°F), blood pressure is 118/76 mm Hg, pulse is 74/min, and respirations are 14/min. Her BMI is 22 kg/m². Pelvic examination shows normal external genitalia and a normal-appearing cervix, but the vaginal mucosa appears pale and thin. A urine pregnancy test in the office is negative. Arrange the following steps in the most appropriate chronological sequence for the diagnostic evaluation and comprehensive management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first measure initial FSH/TSH/prolactin, then confirm with a repeat FSH in 4 weeks, followed by an etiological genetic/autoimmune workup, initiation of hormone replacement therapy, and finally fertility counseling regarding donor oocytes.
The evaluation of secondary amenorrhea with vasomotor symptoms in a young woman requires a precise, stepwise algorithmic approach. Following a negative pregnancy test, the initial step is to measure FSH, TSH, and prolactin to rule out thyroid and pituitary causes, expecting an elevated FSH due to loss of negative feedback from ovarian estrogen. However, the diagnosis of Primary Ovarian Insufficiency (POI) cannot be made on a single value; it must be confirmed with a second elevated FSH level drawn at least four weeks later. Once the diagnosis is definitively confirmed, an etiological workup is mandatory for all women under 40 to identify potential genetic causes (karyotype for Turner mosaicism, FMR1 for Fragile X premutation) or autoimmune associations (adrenal autoantibodies). Following the diagnostic workup, management focuses on lifelong health maintenance and fertility. Systemic estrogen therapy (with a progestogen to protect the endometrium) must be initiated and continued until the natural age of menopause (approximately 50-51 years) to prevent osteoporosis and cardiovascular disease. Finally, because the ovaries are depleted of viable follicles, the patient must be counseled that in vitro fertilization using donor oocytes is the only reliable option for future fertility.

Step-by-Step Solution

1
Identify the clinical presentation and likely underlying pathophysiology.
The patient has secondary amenorrhea, vasomotor symptoms (hot flashes), and vaginal atrophy (pale, thin mucosa) indicating a hypoestrogenic state.
This combination of features in a young woman strongly suggests premature depletion of ovarian follicles, known as Primary Ovarian Insufficiency (POI).
2
Determine the initial diagnostic laboratory sequence.
Following a negative pregnancy test, serum FSH, TSH, and prolactin must be measured.
This is the standard initial biochemical workup for secondary amenorrhea to rule out hyperprolactinemia, hypothyroidism, and ovarian failure.
3
Establish the strict criteria for confirming the diagnosis.
A repeat FSH measurement must be obtained after at least one month.
POI diagnosis requires two elevated FSH levels (>40 mIU/mL) drawn at least 4 weeks apart, as a single reading can be a transient fluctuation.
4
Investigate the underlying etiology of the confirmed condition.
Genetic testing (karyotype, FMR1) and autoimmune screening (adrenal antibodies) are ordered.
Women under 40 with POI have a high risk of chromosomal abnormalities (Turner mosaicism), Fragile X premutation, and autoimmune adrenalitis.
5
Plan long-term medical and reproductive management.
Initiate estrogen and progestin therapy, and counsel regarding in vitro fertilization with donor oocytes.
Hormone replacement is crucial to prevent rapid bone loss and cardiovascular disease, and donor eggs are required due to near-zero spontaneous ovulation rates.

Key Concept

The stepwise diagnostic and management algorithm for Primary Ovarian Insufficiency (POI)
Estimated Time:2m 30s
Question 957Question →

A 2828-year-old female seeks evaluation alongside her partner due to primary infertility. The couple has been engaging in regular, unprotected vaginal intercourse for 1414 months without achieving conception. Her menarche occurred at age 1212. Her menstrual cycles are highly regular, occurring every 2828 days with 55 days of moderate bleeding. She utilizes a home basal body temperature tracking method, which consistently demonstrates a biphasic monthly pattern. Five years ago, she was treated for a sexually transmitted pelvic infection with a single dose of intramuscular ceftriaxone and a 1414-day course of oral doxycycline. She takes a daily prenatal vitamin. Her body mass index is 23 kg/m223 \text{ kg/m}^2. Vital signs are within normal limits. Physical examination reveals normal female hair distribution, absent galactorrhea, and no cutaneous manifestations of hyperandrogenism. Pelvic examination is unremarkable, with no cervical motion tenderness or adnexal masses.

Recent laboratory studies reveal:
Thyroid-stimulating hormone: 1.8μU/mL1.8 \mu\text{U/mL}
Prolactin: 12 ng/mL12 \text{ ng/mL}
Day 2121 serum progesterone: 14 ng/mL14 \text{ ng/mL}

Her partner's semen analysis shows a volume of 3.2 mL3.2 \text{ mL}, a sperm concentration of 55×106/mL55 \times 10^6/\text{mL}, 65%65\% progressive motility, and 8%8\% normal morphology.

Based on the provided clinical data, what is the most appropriate next diagnostic step for this couple?

Show answer & explanation

Answer: Fluoroscopic examination of the uterus and fallopian tubes

Answer

The most appropriate next step is a fluoroscopic examination of the uterus and fallopian tubes (hysterosalpingography).
The correct answer involves performing a hysterosalpingography. The initial diagnostic approach to infertility involves evaluating three primary axes: male factors, ovulatory function, and tubal/uterine anatomy. In this scenario, the partner's semen analysis is normal, eliminating a major male factor. The patient's regular menses, biphasic basal body temperature, and day 21 progesterone level of 14 ng/mL (values >3 ng/mL confirm ovulation) demonstrate normal ovulatory function. Given her history of a pelvic infection (PID), she is at high risk for tubal factor infertility due to post-inflammatory scarring and tubal occlusion. Therefore, structural evaluation of the fallopian tubes via hysterosalpingography is the most critical next step.

Step-by-Step Solution

1
Analyze the male partner's contribution to the couple's infertility.
The semen analysis demonstrates normal volume, concentration, progressive motility, and morphology.
Semen analysis is a primary component of infertility workup; normal results rule out severe male factor infertility.
2
Assess the patient's ovulatory status based on history and laboratory findings.
The patient has regular menstrual cycles, a biphasic basal body temperature, and a day 21 progesterone level >3 ng/mL.
These findings definitively confirm that the patient is experiencing normal, regular ovulation, ruling out anovulatory disorders such as PCOS or functional hypothalamic amenorrhea.
3
Evaluate the patient's anatomical risk factors to determine the next diagnostic step.
The patient has a known history of a sexually transmitted pelvic infection (PID).
PID is a major risk factor for fallopian tube scarring and obstruction. Because male and ovulatory factors are normal, the structural integrity of the reproductive tract must be assessed via hysterosalpingography.

Key Concept

The initial evaluation of primary infertility requires a systematic assessment of male factors (semen analysis), ovulatory factors (menstrual history, mid-luteal progesterone), and anatomical factors (tubal patency via hysterosalpingography), particularly when historical risk factors for tubal disease are present.
Question 958Question →

A 55-year-old female patient presents to the urogynecology clinic seeking evaluation for involuntary urinary leakage. She reports experiencing a sudden, overwhelming need to void that she frequently cannot suppress, resulting in loss of urine before reaching the restroom. These episodes happen 5 to 6 times daily and wake her up twice nightly. She specifically denies any leakage associated with sneezing, coughing, or physical exertion. Her medical history is unremarkable. Pelvic examination demonstrates normal vaginal estrogenization with no evidence of pelvic organ prolapse. Urinalysis is negative for infection, and post-void residual volume is 25 mL. She is highly motivated to undergo treatment. Arrange the following management strategies for this patient's diagnosis in the correct sequential order, starting from the most appropriate initial intervention to the most advanced, last-resort therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management begins with behavioral modifications, progresses to pharmacotherapy, is followed by minimally invasive procedures like intradetrusor botulinum toxin A, and culminates in advanced therapies such as sacral neuromodulation.
The management of urgency urinary incontinence and overactive bladder follows a strict, stepwise clinical pathway designed to minimize patient morbidity while maximizing therapeutic benefit. Behavioral modifications must be trialed first. If these fail, pharmacotherapy is instituted. Only when patients are refractory to or intolerant of medications should third-line (intradetrusor botulinum toxin A) and fourth-line (sacral neuromodulation) options be offered.

Step-by-Step Solution

1
Diagnose the underlying cause of the patient's urinary leakage.
The clinical presentation is consistent with urgency urinary incontinence (UUI).
The patient experiences a sudden, compelling urge to void accompanied by involuntary leakage, without any association with increased intra-abdominal pressure (which would suggest stress incontinence).
2
Identify the standard first-line therapy for urgency urinary incontinence.
Behavioral modifications.
Non-invasive interventions such as fluid restriction, avoidance of bladder irritants, and pelvic floor muscle training are highly effective and carry no risk of adverse medication effects.
3
Determine the appropriate escalation to second-line therapy.
Pharmacotherapy.
If behavioral modifications are insufficient, medications that relax the detrusor muscle (antimuscarinics or beta-3 agonists) are the next appropriate step.
4
Sequence the remaining refractory third-line and fourth-line treatments.
Minimally invasive procedures followed by advanced surgical interventions.
Intradetrusor botulinum toxin A or percutaneous tibial nerve stimulation are utilized before proceeding to highly invasive and permanent solutions like sacral neuromodulation.

Key Concept

Stepwise escalation of management for urgency urinary incontinence
Question 959Question →

A 64-year-old woman with a history of obesity, chronic hypertension, and type 2 diabetes mellitus presents to the clinic reporting two weeks of daily, unprovoked vaginal bleeding. She experienced natural menopause at age 52 and has never used hormone replacement therapy. Pelvic examination is unremarkable, and a transvaginal ultrasound reveals an irregular, heterogeneous endometrial stripe measuring 16 mm. Arrange the following steps in the most appropriate chronological sequence for the diagnostic evaluation and definitive management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Endometrial biopsy, 2) Preoperative pelvic MRI, 3) Total hysterectomy with BSO and lymph node mapping, 4) FIGO surgical staging, 5) Adjuvant radiotherapy.
The standard of care for postmenopausal bleeding with a thickened endometrium follows a strict progression: initial histologic diagnosis (endometrial biopsy), followed by preoperative imaging (pelvic MRI) to plan the surgical approach, proceeding to surgical resection and staging (hysterectomy/BSO/lymph node mapping), followed by pathological FIGO staging, and concluding with risk-adapted adjuvant therapy (radiation/chemotherapy).

Step-by-Step Solution

1
Obtain primary tissue diagnosis
Endometrial biopsy confirms the presence of endometrioid adenocarcinoma
A thickened endometrial stripe (>4 mm) in the setting of postmenopausal bleeding requires immediate histologic evaluation.
2
Perform preoperative radiological staging
Pelvic MRI assesses the depth of myometrial invasion and checks for cervical stroma involvement
Preoperative knowledge of cervical involvement is required to determine whether the patient needs a simple or radical hysterectomy.
3
Execute primary surgical management
Total extrafascial hysterectomy, bilateral salpingo-oophorectomy, and sentinel lymph node assessment are performed
This is the standard definitive surgical treatment for clinically early-stage endometrial cancer.
4
Determine pathological stage
A definitive FIGO stage is assigned based on the surgical specimen
Unlike cervical cancer which can be clinically staged, endometrial cancer requires comprehensive surgical and pathological staging.
5
Administer stage-appropriate adjuvant therapy
Adjuvant radiation (e.g., vaginal brachytherapy) is administered
Adjuvant treatment reduces the risk of vaginal cuff recurrence in patients with intermediate or high-risk pathological features.

Key Concept

The chronological diagnostic and therapeutic care pathway for endometrial carcinoma, progressing from tissue diagnosis to imaging, surgical staging, pathological review, and adjuvant therapy.
Estimated Time:1m 30s
Question 960Question →

Match each patient's clinical scenario regarding primary infertility with the most appropriate primary treatment modality or next best step in management to achieve conception.

Click a left item, then click its matching right item

Items

A 29-year-old nulligravida presents with infertility for 18 months. BMI is 34 kg/m², BP 120/80 mmHg. She has oligomenorrhea and severe acne. Hysterosalpingogram and partner's semen analysis are normal.
A 32-year-old nulligravida presents with infertility for 2 years. BMI is 22 kg/m², BP 110/70 mmHg. Menses are regular. History includes ruptured appendicitis. Hysterosalpingogram demonstrates bilateral proximal fallopian tube occlusion.
A 27-year-old nulligravida presents with infertility for 14 months. BMI is 24 kg/m², BP 115/75 mmHg. Menses are regular. Her partner has cystic fibrosis and bilateral absence of the vas deferens.
A 35-year-old nulligravida presents with 8 months of amenorrhea, hot flashes, and infertility. BMI is 21 kg/m², BP 125/82 mmHg. Serum FSH is 72 mIU/mL and estradiol is 15 pg/mL.
A 30-year-old nulligravida presents with infertility, galactorrhea, and amenorrhea. BMI is 25 kg/m², BP 118/76 mmHg. Brain MRI reveals a 5-mm pituitary adenoma. Partner's semen analysis is normal.

Matches

Show answer & explanation

Answer

Each distinct etiology of infertility necessitates a targeted therapeutic approach ranging from medical ovulation induction to advanced assisted reproductive technologies like standard IVF, ICSI, or the use of donor oocytes.
Matching appropriate fertility treatments requires synthesizing clinical data. PCOS (high BMI, hyperandrogenism) is best treated with letrozole. Tubal disease (history of ruptured appendicitis) requires IVF to bypass the occlusion. Cystic fibrosis in the male partner causes CBAVD, requiring surgical sperm retrieval and ICSI. Primary ovarian insufficiency (high FSH, low estrogen) lacks viable endogenous follicles, requiring donor oocytes. Prolactinomas cause reversible anovulation that responds excellently to dopamine agonists.

Step-by-Step Solution

1
Evaluate the primary pathophysiologic cause of infertility for each couple based on their history, physical examination, and diagnostic testing.
Pathologies are identified as anovulatory (PCOS, prolactinoma), anatomic (tubal occlusion), male factor (obstructive azoospermia), or related to depleted reserve (primary ovarian insufficiency).
Accurate localization of the reproductive defect is required before initiating therapy.
2
Determine if the condition can be medically corrected to allow in vivo fertilization or if in vitro bypass techniques are mandated.
PCOS and prolactinomas are managed medically to restore ovulation. Tubal occlusion and severe male factor infertility mandate in vitro bypass.
Medical therapy cannot overcome absolute physical barriers to sperm-ovum union.
3
Select the specific evidence-based intervention for the diagnosed pathology.
Letrozole for PCOS, cabergoline for prolactinoma, standard IVF for tubal factor, ICSI for CBAVD, and donor oocytes for primary ovarian insufficiency.
These represent the standard-of-care next steps aligned with current ACOG and ASRM guidelines.

Key Concept

The management of infertility is highly etiology-specific: anovulatory disorders often respond to medical induction, structural tubal disease requires standard IVF, severe male factor requires ICSI, and absent ovarian reserve requires donor oocytes.
PreviousPage 48 / 53Next